Early effect of Roux-en-Y gastric bypass on insulin sensitivity and signaling.
暂无分享,去创建一个
A. Gastaldelli | M. Raffaelli | R. Bellantone | G. Mingrone | E. Capristo | A. Iaconelli | C. Guidone | A. Severino | C. Callari | L. Castagneto-Gissey
[1] J. Holst,et al. Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass , 2014, Diabetes.
[2] I. Kim,et al. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W. , 2013, Biochimica et biophysica acta.
[3] E. Fliers,et al. Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery , 2013, Obesity.
[4] J. Holst,et al. Increased hepatic insulin clearance after Roux-en-Y gastric bypass. , 2013, The Journal of clinical endocrinology and metabolism.
[5] S. Salinari,et al. Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance , 2013, PloS one.
[6] B. Su,et al. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. , 2012, Molecular cell.
[7] Alan R. Saltiel,et al. Regulation of glucose transport by insulin: traffic control of GLUT4 , 2012, Nature Reviews Molecular Cell Biology.
[8] J. Holst,et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass , 2012, Diabetologia.
[9] F. Rubino,et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. , 2012, The New England journal of medicine.
[10] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[11] R. Yanagisawa,et al. Insulin resistance and bariatric surgery , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[12] M. Ceccarelli,et al. Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase , 2012, PloS one.
[13] N. Abumrad,et al. Hepatic and Peripheral Insulin Sensitivity and Diabetes Remission at 1 Month After Roux-en-Y Gastric Bypass Surgery in Patients Randomized to Omentectomy , 2011, Diabetes Care.
[14] D. Schroeder,et al. Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. , 2011, American journal of physiology. Endocrinology and metabolism.
[15] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[16] J. Auwerx,et al. mTOR complex 2 in adipose tissue negatively controls whole-body growth , 2009, Proceedings of the National Academy of Sciences.
[17] A. Mari,et al. Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.
[18] A. Marette,et al. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. , 2005, Endocrinology.
[19] G. Mills,et al. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells , 2003, Oncogene.
[20] Y. Kido,et al. CEACAM1 regulates insulin clearance in liver , 2002, Nature Genetics.
[21] A. Saltiel,et al. Signaling pathways in insulin action: molecular targets of insulin resistance. , 2000, The Journal of clinical investigation.
[22] F. McCormick,et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.
[23] P. Cohen,et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.
[24] A. Scheen,et al. How to measure insulin clearance. , 1994, Diabetes/metabolism reviews.
[25] Y. Le Marchand-Brustel,et al. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. , 2005, Biochimie.